$RGNX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENXBIO Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in REGENXBIO Inc.. Get notifications about new insider transactions in REGENXBIO Inc. for free.
Page: < prev 1 2 3 4 5 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 63.45 | 100 | 6,345 | 208,230 | 208.3 K to 208.2 K (-0.05 %) |
| Jun 22 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 61.70 | 200 | 12,340 | 208,330 | 208.5 K to 208.3 K (-0.10 %) |
| Jun 20 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | M | 12.10 | 1,528 | 18,489 | 68,472 | |
| Jun 20 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | M | 12.10 | 5,000 | 60,500 | 70,000 | |
| Jun 20 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Buy | M | 12.10 | 1,528 | 18,489 | 17,669 | 16.1 K to 17.7 K (+9.47 %) |
| Jun 20 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 56.91 | 4,600 | 261,786 | 16,141 | 20.7 K to 16.1 K (-22.18 %) |
| Jun 20 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 55.25 | 400 | 22,100 | 20,741 | 21.1 K to 20.7 K (-1.89 %) |
| Jun 20 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Buy | M | 12.10 | 5,000 | 60,500 | 21,141 | 16.1 K to 21.1 K (+30.98 %) |
| Jun 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 56.90 | 4,343 | 247,117 | 137,283 | 141.6 K to 137.3 K (-3.07 %) |
| Jun 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 56.20 | 3,157 | 177,423 | 141,626 | 144.8 K to 141.6 K (-2.18 %) |
| Jun 05 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 14,900 | 12,665 | 189,100 | ||
| Jun 05 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 100 | 85 | 204,000 | ||
| Jun 05 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 55.01 | 14,900 | 819,649 | 0 | 14.9 K to 0 (-100.00 %) | |
| Jun 05 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 14,900 | 12,665 | 14,900 | 0 to 14.9 K | |
| Jun 05 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 55.00 | 100 | 5,500 | 0 | 100 to 0 (-100.00 %) | |
| Jun 05 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 100 | 85 | 100 | 0 to 100 | |
| May 30 2018 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Option Exercise | A | 49.45 | 12,500 | 618,125 | 12,500 | ||
| May 30 2018 | RGNX | REGENXBIO Inc. | Tasse Daniel | Option Exercise | A | 49.45 | 12,500 | 618,125 | 12,500 | ||
| May 30 2018 | RGNX | REGENXBIO Inc. | STUMP DAVID C | Option Exercise | A | 49.45 | 12,500 | 618,125 | 12,500 | ||
| May 30 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | A | 49.45 | 12,500 | 618,125 | 12,500 | ||
| May 30 2018 | RGNX | REGENXBIO Inc. | Fox Allan M. | Option Exercise | A | 49.45 | 12,500 | 618,125 | 12,500 | ||
| May 30 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | A | 49.45 | 12,500 | 618,125 | 12,500 | ||
| May 30 2018 | RGNX | REGENXBIO Inc. | Abdun-Nabi Daniel | Option Exercise | A | 49.45 | 12,500 | 618,125 | 12,500 | ||
| May 30 2018 | RGNX | REGENXBIO Inc. | Glucksmann Alexandra | Option Exercise | A | 49.45 | 25,000 | 1,236,250 | 25,000 | ||
| May 23 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 48.39 | 1,401 | 67,794 | 208,530 | 209.9 K to 208.5 K (-0.67 %) |
| May 23 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 47.88 | 1,800 | 86,184 | 209,931 | 211.7 K to 209.9 K (-0.85 %) |
| May 23 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 46.56 | 6,799 | 316,561 | 211,731 | 218.5 K to 211.7 K (-3.11 %) |
| May 16 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 50.76 | 2,455 | 124,616 | 144,783 | 147.2 K to 144.8 K (-1.67 %) |
| May 16 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 49.93 | 3,945 | 196,974 | 147,238 | 151.2 K to 147.2 K (-2.61 %) |
| May 16 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 49.21 | 1,100 | 54,131 | 151,183 | 152.3 K to 151.2 K (-0.72 %) |
| May 16 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 9,847 | 8,370 | 204,100 | ||
| May 16 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 5,153 | 4,380 | 213,947 | ||
| May 16 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 50.06 | 9,847 | 492,941 | 0 | 9.8 K to 0 (-100.00 %) | |
| May 16 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 9,847 | 8,370 | 9,847 | 0 to 9.8 K | |
| May 16 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 50.04 | 5,153 | 257,856 | 0 | 5.2 K to 0 (-100.00 %) | |
| May 16 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 5,153 | 4,380 | 5,153 | 0 to 5.2 K | |
| May 11 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | M | 12.10 | 15,000 | 181,500 | 75,000 | |
| May 11 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | M | 12.10 | 15,000 | 181,500 | 90,000 | |
| May 11 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Buy | M | 12.10 | 15,000 | 181,500 | 16,141 | 1.1 K to 16.1 K (+1,314.64 %) |
| May 11 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 44.00 | 10,000 | 440,000 | 1,141 | 11.1 K to 1.1 K (-89.76 %) |
| May 11 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 42.00 | 5,000 | 210,000 | 11,141 | 16.1 K to 11.1 K (-30.98 %) |
| May 11 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Buy | M | 12.10 | 15,000 | 181,500 | 16,141 | 1.1 K to 16.1 K (+1,314.64 %) |
| May 11 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 15,000 | 12,750 | 219,100 | ||
| May 11 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 45.00 | 15,000 | 675,000 | 0 | 15 K to 0 (-100.00 %) | |
| May 11 2018 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 15,000 | 12,750 | 15,000 | 0 to 15 K | |
| Apr 24 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 39.93 | 900 | 35,937 | 218,530 | 219.4 K to 218.5 K (-0.41 %) |
| Apr 24 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 39.48 | 9,100 | 359,268 | 219,430 | 228.5 K to 219.4 K (-3.98 %) |
| Apr 18 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 37.85 | 2,151 | 81,415 | 152,283 | 154.4 K to 152.3 K (-1.39 %) |
| Apr 18 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 37.34 | 2,849 | 106,382 | 154,434 | 157.3 K to 154.4 K (-1.81 %) |
| Apr 13 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | M | 12.10 | 10,000 | 121,000 | 105,000 | |
| Apr 13 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 39.00 | 10,000 | 390,000 | 1,141 | 11.1 K to 1.1 K (-89.76 %) |
| Apr 13 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Buy | M | 12.10 | 10,000 | 121,000 | 11,141 | 1.1 K to 11.1 K (+876.42 %) |
| Apr 11 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | M | 12.10 | 10,000 | 121,000 | 115,000 | |
| Apr 11 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 34.00 | 10,000 | 340,000 | 1,141 | 11.1 K to 1.1 K (-89.76 %) |
| Apr 11 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Buy | M | 12.10 | 10,000 | 121,000 | 11,141 | 1.1 K to 11.1 K (+876.42 %) |
| Mar 28 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 30.00 | 5,000 | 150,000 | 157,283 | 162.3 K to 157.3 K (-3.08 %) |
| Mar 22 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 29.55 | 10,000 | 295,500 | 228,530 | 238.5 K to 228.5 K (-4.19 %) |
| Mar 15 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 22.00 | 25,000 | 550,000 | 155,500 | |
| Mar 15 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 33.00 | 25,000 | 825,000 | 39,500 | 64.5 K to 39.5 K (-38.76 %) |
| Mar 15 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 22.00 | 25,000 | 550,000 | 64,500 | 39.5 K to 64.5 K (+63.29 %) |
| Mar 08 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 0.85 | 60,000 | 51,000 | 234,900 | |
| Mar 08 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 0.85 | 60,000 | 51,000 | 162,283 | 102.3 K to 162.3 K (+58.66 %) |
| Feb 22 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 26.56 | 10,000 | 265,600 | 238,530 | 248.5 K to 238.5 K (-4.02 %) |
| Jan 24 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 27.33 | 10,000 | 273,300 | 248,530 | 258.5 K to 248.5 K (-3.87 %) |
| Jan 18 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 30.16 | 5,000 | 150,800 | 107,283 | 112.3 K to 107.3 K (-4.45 %) |
| Jan 16 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 150,000 | 127,500 | 379,670 | |
| Jan 16 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 150,000 | 127,500 | 258,530 | 108.5 K to 258.5 K (+138.21 %) |
| Jan 09 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 0.85 | 30,000 | 25,500 | 294,900 | |
| Jan 09 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 0.85 | 30,000 | 25,500 | 112,283 | 82.3 K to 112.3 K (+36.46 %) |
| Jan 05 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | A | 35.80 | 43,000 | 1,539,400 | 43,000 | |
| Jan 05 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Grant | A | 17.43 | 486 | 8,469 | 1,141 | 655 to 1.1 K (+74.20 %) |
| Jan 05 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Grant | A | 15.73 | 655 | 10,300 | 655 | 0 to 655 |
| Jan 05 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | A | 35.80 | 55,000 | 1,969,000 | 55,000 | |
| Jan 05 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | A | 35.80 | 55,000 | 1,969,000 | 55,000 | |
| Jan 05 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | A | 35.80 | 41,250 | 1,476,750 | 41,250 | |
| Jan 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | A | 35.80 | 55,000 | 1,969,000 | 55,000 | |
| Jan 05 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | A | 35.80 | 163,500 | 5,853,300 | 163,500 | |
| Dec 27 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 22.00 | 30,000 | 660,000 | 180,500 | |
| Dec 27 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 33.03 | 30,000 | 990,900 | 39,500 | 69.5 K to 39.5 K (-43.17 %) |
| Dec 27 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 22.00 | 30,000 | 660,000 | 69,500 | 39.5 K to 69.5 K (+75.95 %) |
| Dec 21 2017 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 31.75 | 10,000 | 317,500 | 108,530 | 118.5 K to 108.5 K (-8.44 %) |
| Dec 20 2017 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 30.00 | 4,994 | 149,820 | 82,283 | 87.3 K to 82.3 K (-5.72 %) |
| Dec 20 2017 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 30.00 | 6 | 180 | 87,277 | 87.3 K to 87.3 K (-0.01 %) |
| Dec 11 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 22.00 | 20,000 | 440,000 | 210,500 | |
| Dec 11 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 13.09 | 1,890 | 24,740 | 6,000 | |
| Dec 11 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 30.04 | 21,890 | 657,576 | 39,500 | 61.4 K to 39.5 K (-35.66 %) |
| Dec 11 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 22.00 | 20,000 | 440,000 | 61,390 | 41.4 K to 61.4 K (+48.32 %) |
| Dec 11 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 13.09 | 1,890 | 24,740 | 41,390 | 39.5 K to 41.4 K (+4.78 %) |
| Dec 06 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 13.09 | 110 | 1,440 | 7,890 | |
| Dec 06 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 30.00 | 110 | 3,300 | 39,500 | 39.6 K to 39.5 K (-0.28 %) |
| Dec 06 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 13.09 | 110 | 1,440 | 39,610 | 39.5 K to 39.6 K (+0.28 %) |
| Nov 29 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 13.09 | 2,000 | 26,180 | 8,000 | |
| Nov 29 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 29.31 | 2,000 | 58,620 | 39,500 | 41.5 K to 39.5 K (-4.82 %) |
| Nov 29 2017 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 13.09 | 2,000 | 26,180 | 41,500 | 39.5 K to 41.5 K (+5.06 %) |
| Nov 21 2017 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 30,000 | 25,500 | 529,670 | |
| Nov 21 2017 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 27.71 | 10,000 | 277,100 | 118,530 | 128.5 K to 118.5 K (-7.78 %) |
| Nov 21 2017 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 30,000 | 25,500 | 128,530 | 98.5 K to 128.5 K (+30.45 %) |
| Nov 17 2017 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 25.30 | 5,000 | 126,500 | 87,283 | 92.3 K to 87.3 K (-5.42 %) |
| Oct 24 2017 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 33.03 | 200 | 6,606 | 98,530 | 98.7 K to 98.5 K (-0.20 %) |
| Oct 24 2017 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 32.61 | 9,800 | 319,578 | 98,730 | 108.5 K to 98.7 K (-9.03 %) |
| Oct 18 2017 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 33.25 | 5,000 | 166,250 | 92,283 | 97.3 K to 92.3 K (-5.14 %) |
| Oct 13 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 20,000 | 17,000 | 234,100 | ||
| Oct 13 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 34.95 | 20,000 | 699,000 | 0 | 20 K to 0 (-100.00 %) | |
| Oct 13 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 20,000 | 17,000 | 20,000 | 0 to 20 K | |
| Sep 29 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 20,000 | 17,000 | 254,100 | ||
| Sep 29 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 32.45 | 20,000 | 649,000 | 0 | 20 K to 0 (-100.00 %) | |
| Sep 29 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 20,000 | 17,000 | 20,000 | 0 to 20 K | |
| Sep 22 2017 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 30.05 | 100 | 3,005 | 108,530 | 108.6 K to 108.5 K (-0.09 %) |
| Sep 22 2017 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 29.32 | 9,900 | 290,268 | 108,630 | 118.5 K to 108.6 K (-8.35 %) |
| Sep 19 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 20,000 | 17,000 | 274,100 | ||
| Sep 19 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 20,000 | 17,000 | 294,100 | ||
| Sep 19 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 29.95 | 20,000 | 599,000 | 0 | 20 K to 0 (-100.00 %) | |
| Sep 19 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 20,000 | 17,000 | 20,000 | 0 to 20 K | |
| Sep 19 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 27.45 | 20,000 | 549,000 | 0 | 20 K to 0 (-100.00 %) | |
| Sep 19 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 20,000 | 17,000 | 20,000 | 0 to 20 K | |
| Sep 19 2017 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 27.74 | 2,311 | 64,107 | 97,283 | 99.6 K to 97.3 K (-2.32 %) |
| Sep 19 2017 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 27.08 | 2,689 | 72,818 | 99,594 | 102.3 K to 99.6 K (-2.63 %) |
| Sep 12 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 27,342 | 23,241 | 142,900 | |
| Sep 12 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 25.00 | 27,342 | 683,550 | 0 | 27.3 K to 0 (-100.00 %) |
| Sep 12 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 27,342 | 23,241 | 27,342 | 0 to 27.3 K |
| Sep 07 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 20,000 | 17,000 | 314,100 | ||
| Sep 07 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 24.95 | 20,000 | 499,000 | 0 | 20 K to 0 (-100.00 %) | |
| Sep 07 2017 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 20,000 | 17,000 | 20,000 | 0 to 20 K | |
| Sep 07 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 855 | 727 | 170,242 | |
| Sep 07 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 31,803 | 27,033 | 171,097 | |
| Sep 07 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 25.00 | 855 | 21,375 | 0 | 855 to 0 (-100.00 %) |
| Sep 07 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 855 | 727 | 855 | 0 to 855 |
| Sep 07 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 25.00 | 31,803 | 795,075 | 0 | 31.8 K to 0 (-100.00 %) |
| Sep 07 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 31,803 | 27,033 | 31,803 | 0 to 31.8 K |
| Sep 07 2017 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 25.00 | 10,500 | 262,500 | 118,530 | 129 K to 118.5 K (-8.14 %) |
| Aug 29 2017 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 23,530 | 20,001 | 559,670 | |
| Aug 29 2017 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 23,530 | 20,001 | 129,030 | 105.5 K to 129 K (+22.30 %) |
| Aug 23 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 15,000 | 12,750 | 202,900 | |
| Aug 23 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 20.03 | 15,000 | 300,450 | 0 | 15 K to 0 (-100.00 %) |
| Aug 23 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 15,000 | 12,750 | 15,000 | 0 to 15 K |
| Aug 23 2017 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 20.05 | 6,500 | 130,325 | 105,500 | 112 K to 105.5 K (-5.80 %) |
| Aug 17 2017 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 21.43 | 835 | 17,894 | 102,283 | 103.1 K to 102.3 K (-0.81 %) |
| Aug 17 2017 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 20.96 | 2,205 | 46,217 | 103,118 | 105.3 K to 103.1 K (-2.09 %) |
| Jul 24 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 15,000 | 12,750 | 217,900 | |
| Jul 24 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 18.66 | 15,000 | 279,900 | 0 | 15 K to 0 (-100.00 %) |
| Jul 24 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 15,000 | 12,750 | 15,000 | 0 to 15 K |
| Jul 24 2017 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 18.66 | 6,500 | 121,290 | 112,000 | 118.5 K to 112 K (-5.49 %) |
| Jul 19 2017 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 19.81 | 3,100 | 61,411 | 105,323 | 108.4 K to 105.3 K (-2.86 %) |
| Jul 19 2017 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Grant | A | 15.73 | 911 | 14,325 | 108,423 | 107.5 K to 108.4 K (+0.85 %) |
| Jun 22 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 15,000 | 12,750 | 232,900 | |
| Jun 22 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 20.14 | 1,900 | 38,266 | 0 | 1.9 K to 0 (-100.00 %) |
| Jun 22 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 19.61 | 13,100 | 256,891 | 1,900 | 15 K to 1.9 K (-87.33 %) |
| Jun 22 2017 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 15,000 | 12,750 | 15,000 | 0 to 15 K |
| Jun 22 2017 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 20.16 | 896 | 18,063 | 118,500 | 119.4 K to 118.5 K (-0.75 %) |
| Jun 22 2017 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 19.60 | 5,604 | 109,838 | 119,396 | 125 K to 119.4 K (-4.48 %) |